[Exploration on strategies and methodology of study of objectified therapeutic effectiveness and evaluation on malignant tumor treated with traditional Chinese medicine].
Correction of malignant behavior of tumor cells by traditional Chinese herb medicine through a restoration of p53.
[Discussion and preliminary application on standard for comprehensive efficacy assessment of traditional Chinese medicine in treating malignant tumor].
Nanodelivery system of traditional Chinese medicine bioactive compounds: Application in the treatment of prostate cancer.
Zou B, Long Y, Gao R, Liu Q, Tian X, Liu B, Zhou Q.
Phytomedicine. 2024 Dec;135:155554. doi: 10.1016/j.phymed.2024.155554. Epub 2024 Mar 29.
Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy.
Zhu LR, Li SS, Zheng WQ, Ni WJ, Cai M, Liu HP.
Front Immunol. 2023 Feb 2;14:1086078. doi: 10.3389/fimmu.2023.1086078. eCollection 2023.
Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment.
Zhang Y, Lou Y, Wang J, Yu C, Shen W.
Front Immunol. 2021 Jan 21;11:609705. doi: 10.3389/fimmu.2020.609705. eCollection 2020.
Traditional Chinese medicine for precancerous lesions of gastric cancer: A review.
Xu W, Li B, Xu M, Yang T, Hao X.
Biomed Pharmacother. 2022 Feb;146:112542. doi: 10.1016/j.biopha.2021.112542. Epub 2021 Dec 20.
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science.
Xiang Y, Guo Z, Zhu P, Chen J, Huang Y.
Cancer Med. 2019 May;8(5):1958-1975. doi: 10.1002/cam4.2108. Epub 2019 Apr 3.
The positive role of traditional Chinese medicine as an adjunctive therapy for cancer.
Zhang X, Qiu H, Li C, Cai P, Qi F.
Biosci Trends. 2021 Nov 21;15(5):283-298. doi: 10.5582/bst.2021.01318. Epub 2021 Aug 20.
Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy.
Miao K, Liu W, Xu J, Qian Z, Zhang Q.
Front Immunol. 2023 Nov 15;14:1277243. doi: 10.3389/fimmu.2023.1277243. eCollection 2023.
Targeting tumor-associated macrophage polarization with traditional Chinese medicine active ingredients: Dual reversal of chemoresistance and immunosuppression in tumor microenvironment.
Qi Y, Yan J, Huang X, Jiang X, Li R, Wan J, Li Y, Miao Z, Song Z, Liu Y, Zhang L, Zhang Z.
Pharmacol Res. 2025 Jun;216:107788. doi: 10.1016/j.phrs.2025.107788. Epub 2025 May 23.
Discovery and repurposing of artemisinin.
Shi Q, Xia F, Wang Q, Liao F, Guo Q, Xu C, Wang J.
Front Med. 2022 Feb;16(1):1-9. doi: 10.1007/s11684-021-0898-6. Epub 2022 Mar 15.
The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives.
Wei X, Wang F, Tan P, Huang H, Wang Z, Xie J, Wang L, Liu D, Hu Z.
Pharmacol Res. 2024 May;203:107148. doi: 10.1016/j.phrs.2024.107148. Epub 2024 Mar 22.
